Our team consists of healthcare and IT industry leaders who believe that technology can unleash the power of pharmacogenomics to drive the future of healthcare.
PanGenX was founded in 2010 with the belief that current treatment outcomes can be improved through effective use of clinical genetic data. We have created a deep collaboration between geneticists and computer scientists. This unique combination has led to the creation of scientifically based, technology driven, decision-making applications to improve the lives of millions of patients suffering worldwide. Our passion, combined with tenacious efforts to challenge status quo drives our team to bring personalized medicine to the forefront of healthcare.
Our mission is to advance clinical practice and treatment approaches by integrating genetic variations related to drug response with patient outcomes. We optimize therapeutic care and decision-making by providing pharmaceutical companies, healthcare providers, and payers with tools to conduct analyses and make more informed decisions through the intelligent use of pharmacogenomics, population genetics, and clinical outcomes data. Ultimately, by informed selection of medicines, patients will endure fewer side effects and achieve treatment benefits for debilitating, progressive diseases.